AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer
We believe that AURKAi hold promise as potential therapeutics for ARID1A mutation colorectal cancer patients.
Authors
- Shu Luo
- MingWei Kang
- Rongsheng Qin
- Hao-Wen Hu
- Shan Xu (ORCID: https://orcid.org/0000-0003-0754-0969)
- Fei Chen (ORCID: https://orcid.org/0000-0003-3895-6318)
- Chao Wang (ORCID: https://orcid.org/0000-0002-8592-3781)
- Jie Li (ORCID: https://orcid.org/0000-0003-0605-1506)
- Chuntao Li (ORCID: https://orcid.org/0000-0001-9726-8393)
Institutions
- Southwest Medical University (CN)
- Suizhou Central Hospital (CN)
- Mianyang Central Hospital (CN)
- Sichuan Mianyang 404 Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1007/s12672-024-01433-y
- Citations
- 5
- Primary Topic
- Chromatin Remodeling and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.17